Back to today’s briefing

Story perspectives

Study Links HMGN1 Overexpression to Heart Defects in Down Syndrome

10/23/2025

36 6 Full Breakdown

Summary

Story summary

Researchers identified HMGN1 overexpression as a key contributor to congenital heart defects in Down syndrome.
About 50% of babies with Down syndrome have heart defects, often requiring surgery.
The Nature study used CRISPR and single-cell RNA sequencing to study chromosome 21 gene interactions.
Researchers used mosaic Down syndrome to reduce variability and identified that HMGN1 overexpression alters heart cell development.

1 of 1

Story summary

Researchers identified HMGN1 overexpression as a key contributor to congenital heart defects in Down syndrome.
About 50% of babies with Down syndrome have heart defects, often requiring surgery.
The Nature study used CRISPR and single-cell RNA sequencing to study chromosome 21 gene interactions.
Researchers used mosaic Down syndrome to reduce variability and identified that HMGN1 overexpression alters heart cell development.